Murj, Inc. v. Rhythm Management Group, Inc.

District Court, N.D. California·Decided November 24, 2021·No. 5:21-cv-00072·Unknown

Opinion

MURJ, INC., Case No. 5:21-cv-00072-EJD

Plaintiff, ORDER GRANTING MOTION TO DISMISS AMENDED COMPLAINT v.

RHYTHM MANAGEMENT GROUP, Re: Dkt. No. 26 PLLC, Defendant.

Plaintiff Murj, Inc. (“Murj”) brings this action against Defendant Rhythm Management Group, PLLC (“Rhythm”), asserting three claims related to an alleged contractual relationship between the parties. Before the Court is Rhythm’s motion to dismiss Murj’s amended complaint in its entirety under Federal Rule of Civil Procedure 12(b)(6). Def.’s. Corrected Mot. to Dismiss All Claims in Pl.’s Compl. (“Mot.”), Dkt. No. 26. The Court finds the motion appropriate for decision without oral argument pursuant to Civil Local Rule 7-1(b). For the reasons described below, the Court GRANTS the motion with leave to amend. Plaintiff Murj is the creator of a proprietary cardiac device data management software program (“the Murj Platform”) which allows medical providers to monitor and manage data from a variety of implantable cardiac devices. Am. Compl., Dkt. No. 5 ¶¶ 8-10. Defendant Rhythm provides clinical diagnostic services in the form of monitoring patient data to medical providers. Id. ¶ 12. In particular, Rhythm assists medical providers with tracking and managing data collected from patients’ implanted cardiac devices. Mot. at 2. In August 2018 and January 2019, Murj and Rhythm executed two License Agreements and associated Sales Orders, as well as an agreement that Rhythm would abide by the Murj Inc. License Agreement and Terms & Conditions (“Terms & Conditions”). See Dkt. Nos. 5-1, 5-2, 5- 3, 5-4, 5-5. Under the License Agreements, Sales Orders, and associated Terms & Conditions (collectively, “the Agreement”), Rhythm was authorized to use the Murj Platform for its “internal business purposes, which includes the internal business purposes of any subsidiaries that Customer controls either directly or indirectly.” Dkt. No. 5-2 at Section 3.1. The Terms & Conditions include provisions concerning Rhythm’s use of the Murj Platform. Both parties agreed to “hold each other’s Confidential Information in confidence and not to disclose such information in any form to any third party without the express written consent of the disclosing party” for the term of the Agreement and for at least five years following the Agreement’s expiration. Id. at Section 6.2 (“the confidentiality clause”). “Confidential Information” is defined as including, among other things, the “Application” and “any Products, related documentation, [and] specifications.” Id. at Section 6.1. “Application” is defined as “the software Application developed and delivered by Murj as described on a Sales Order, the related Documentation and updates and enhancements made to the foregoing, if and when made available by Murj.” Id. at Section 1.2. Murj thus asserts the Murj Platform is “specifically defined as ‘Confidential Information’ under the Agreement.” Am. Compl. ¶ 22. Additionally, the Terms & Conditions require Rhythm to not “cause or permit the reverse engineering, disassembly, or decomplication of any portion of” the Murj Platform or “distribute, sell, sublicense, rent, lease or use the [Murj Platform] (or any portion thereof) for time sharing, hosting, service provider or similar purposes.” Id. at Section 3.4 (“the reverse engineering clause”). Rhythm subsequently used the Murj Platform to enable its medical provider customers to monitor and manage data from implantable cardiac devices. Am. Compl. ¶ 23. In mid-2020, Murj discovered that Rhythm had developed its own cardiac monitoring platform (“the Rhythm Platform”). Id. ¶ 24. In a phone call with Murj CEO Todd Butka, Rhythm CEO Rhonda Bray denied that Rhythm was using the Rhythm Platform. Id. ¶ 25. Around this time, Murj assisted Rhythm in selling Rhythm’s services to a customer by demonstrating the Murj Platform for Rhythm to integrate into its sales pitch. Id. ¶ 26. Rhythm’s pitch was successful, but Murj later discovered that Rhythm had provided the customer its own Rhythm Platform instead of the Murj Platform. Id. Murj alleges multiple similarities between its own platform and the Rhythm Platform. Both are capable of “daily monitoring and triaging of customizable alerts,” reviewing and processing multiple transmissions easily, and allowing customers to “customers to collect revenue from remote professional fees without the headache of having to setup and manage remote monitoring themselves.” Id. ¶¶ 28-33. Murj also claims that the Rhythm Platform uses certain design and interface elements taken from the Murj Platform. Id. ¶ 34. Murj says “the user interface, the wording on its website, the layout, the design, and the phrases” as well as the overall appearance of the Rhythm Platform’s “My Agenda” screen are “copies of the Murj Platform.” Id. ¶¶ 34-35. Some of the specific elements Murj alleges Rhythm copied include the use of red, yellow, and green “alert signals” and similar or identical naming conventions for data columns. Id. ¶¶ 36-37. The Murj Platform, for example, organizes patients into “backlog,” “compose,” “needs approval,” and “cleared” categories, while the Rhythm Platform uses “to be done,” “in progress,” “needs approval,” and “cleared” categories arranged in a similar fashion. Id. ¶ 37. Other claimed similarities include “timeline layout, custom color severity, archived transmission indicator, transmission number and colors, workflow layout, transmission count, remote report, needs approval status screen, cancel button, and download button.” Id. ¶ 39. Murj filed this action on January 6, 2021. Dkt. No. 1. Rhythm filed the motion to dismiss now before the Court on March 20, 2021. Dkt. No. 26. Federal Rule of Civil Procedure 8(a) requires a plaintiff to plead each claim with enough specificity to “give the defendant fair notice of what the . . . claim is and the grounds upon which it rests.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007) (internal quotations omitted). A complaint which falls short of the Rule 8(a) standard may therefore be dismissed if it fails to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). “Dismissal under Rule 12(b)(6) is appropriate only where the complaint lacks a cognizable legal theory or sufficient facts to support a cognizable legal theory.” Mendiondo v. Centinela Hosp. Med. Ctr., 521 F.3d 1097, 1104 (9th Cir. 2008). When deciding whether to grant a motion to dismiss, the Court must accept as true all “well pleaded factual allegations” and determine whether the allegations “plausibly give rise to an entitlement to relief.” Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009). The Court must also construe the alleged facts in the light most favorable to the plaintiff. Love v. United States, 915 F.2d 1242, 1245 (9th Cir. 1989). While a complaint need not contain detailed factual allegations, it “must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’” Iqbal, 556 U.S. at 678 (quoting Bell Atl. Corp., 550 U.S. at 570). A court generally may not consider any material beyond the pleadings when ruling on a Rule 12(b)(6) motion. If matters outside the pleadings are considered, “the motion must be treated as one for summary judgment under Rule 56.” Fed. R. Civ. P. 12(d). However, documents appended to the compla

Free access — add to your briefcase to read the full text and ask questions with AI

Murj, Inc. v. Rhythm Management Group, Inc., (N.D. Cal. 2021).

Murj, Inc. v. Rhythm Management Group, Inc. (Murj, Inc. v. Rhythm Management Group, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
1756, Inc. v. Attorney General of the United States
745 F. Supp. 9 (District of Columbia, 1990)
CDF FIREFIGHTERS v. Maldonado
70 Cal. Rptr. 3d 667 (California Court of Appeal, 2008)
Long v. District of Columbia Housing Authority
166 F. Supp. 3d 16 (District of Columbia, 2016)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
Bank of British Columbia v. Frese
47 P. 783 (California Supreme Court, 1897)
Aguilera v. Pirelli Armstrong Tire Corp.
223 F.3d 1010 (Ninth Circuit, 2000)
Adobe Systems Inc. v. A & S Electronics, Inc.
153 F. Supp. 3d 1136 (N.D. California, 2015)